The levels of ESR2 RNA were reduced in adrenocortical carcinoma (ACC), ovarian cancer (OV), pheochromocytoma and paraganglioma (PCPG), and testicular germ cell tumors (TGCTs). Here, ESR2 is linked to paraganglioma.